Modulus Discovery

Modulus Discovery is a Tokyo-based biotechnology startup founded in 2016, specializing in preclinical stage pharmaceutical research. The company's mission, as stated in its slogan, is to advance the future of medicine through innovative computational drug discovery and profound biological insights. Modulus Discovery boasts an international team of experts with prior R&D experience in global pharmaceutical, biotechnology, and computational technology companies.

The company recently secured a ¥2.34B Series C investment on 01 March 2022, with participation from notable investors including Green Co-Invest Investment, Keio Innovation Initiative, UTokyo Innovation Platform, Fast Track Initiative, Inc., Heights Capital Management, and SBI Group.

Modulus Discovery's dedication to leveraging advanced computational drug discovery techniques and unique biological insights to swiftly design and create small molecule clinical candidates targeting significant diseases positions it as an attractive prospect in the rapidly evolving pharmaceutical and biotechnology landscape.